Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Singapore Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20131
20142
20151
20161
20182
20191
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Axovant Sciences Ltd.2
TauRx Therapeutics Ltd2
Eidos Therapeutics, a BridgeBio company1
Eisai Inc.1
GlaxoSmithKline1
H. Lundbeck A/S1
Hoffmann-La Roche1
Moleac Pte Ltd.1
Renew Research, LLC1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease12
Cognitive Dysfunction3
Dementia3
Brain Diseases2
Neurodegenerative Diseases2
Amyloid Neuropathies, Familial1
Amyloidosis1
Cardiomyopathies1
Frontotemporal Dementia1
Heart Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.